CD49b (ITGA2) human monoclonal antibody, clone B4F12
| Applications | ELISA, FC, IF |
| Reactivities | Human |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
| Applications | ELISA, FC, IF |
| Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26C4
| Applications | IF, Neutralize |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC |
| Reactivities | Human |
Recombinant Anti-WDR5 (Clone RAB-C223)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
Recombinant Anti-L3MBTL1 (Clone RAB-C213)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
Recombinant Anti-SETD7 (Clone RAB-C220)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
Recombinant Anti-BRD4 (Clone RAB-C131)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
Anti-Modified cytokeratin [COU-1], Human IgM, kappa
| Applications | ELISA, ICC, IHC, WB |
| Reactivities | Human |
Anti-Laminin-2 LG5 [C3_Hu10], Human IgG1, kappa
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human, Mouse |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26D9
| Applications | IF, Neutralize |
| Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26D9
| Applications | IF, Neutralize |
| Reactivities | Human |
CD70 monoclonal antibody (vorsetuzumab biosimilar)
| Applications | ELISA, FC |
| Reactivities | Human |